James Sapirstein is Chairman at First Wave BioPharma, Inc. (FWBI). They have made 10 open-market trades across 3 companies since 2015, most recently 2024-09-26.
CIK 0001559509
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $15K since 2015, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ENTO | SELL | 2024-07-02 | 2024-07-03 | $1.07 | $1K | N/A | N/A | N/A |
| FWBI | SELL | 2024-04-01 | 2024-04-03 | $4.23 | $736 | N/A | N/A | N/A |
| FWBI | SELL | 2024-03-15 | 2024-03-19 | $4.96 | $9K | N/A | N/A | N/A |
| FWBI | SELL | 2024-01-12 | 2024-01-17 | $4.20 | $697 | N/A | N/A | N/A |
| FWBI | SELL | 2023-10-04 | 2023-10-06 | $0.29 | $802 | N/A | N/A | N/A |
| FWBI | SELL | 2023-07-03 | 2023-07-05 | $1.54 | $5K | N/A | N/A | N/A |
| FWBI | SELL | 2023-04-03 | 2023-04-05 | $2.50 | $8K | N/A | N/A | N/A |
| CTRV | BUY | 2016-02-18 | 2016-02-18 | $1.00 | $10K | -10.9% | +25.7% | -16.8% |
| CTRV | BUY | 2015-11-30 | 2015-12-01 | $2.15 | $1K | -24.7% | +4.0% | -41.3% |
| CTRV | BUY | 2015-11-23 | 2015-11-24 | $1.64 | $4K | -24.7% | +4.0% | -36.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.